Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Breast carcinoma (BC) remains one of the most common and lethal malignancies in women worldwide, making an early and accurate diagnosis a public health priority. Recent artificial intelligence (AI) research has increasingly explored multimodal fusion, with imaging, clinical records, histopathology, and genomic data to produce richer, more reliable predictions. In parallel, explainable AI (XAI) tec...
BACKGROUND: Accurate risk stratification for overall survival (OS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) is critical for guiding personalized treatment and surveillance. A deep learning (DL) model was developed and validated to estimate OS in OPSCC patients based on contrast-enhanced computed tomography (CECT). MATERIALS AND METHODS: A total of 269 patients from three cent...
INTRODUCTION AND OBJECTIVES: An AI model that performs well during training does not guarantee similar performance in clinical practice and should be ...
PURPOSE: To evaluate and compare the performance of diffusion-weighted imaging (DWI) using compressed sensing (CS) and DWI using CS with model-based d...
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options. Wee1 kinase, a critical regulator of th...
PURPOSE: To develop a model-based deep unrolling network for high-quality image reconstruction of accelerated multi-channel chemical exchange saturati...
Artificial intelligence diagnostic tools show promise for improving histotype classification in epithelial ovarian cancer but face challenges due to s...
PURPOSE: To evaluate whether deep learning-based combined noise reduction and contrast enhancement reconstruction (DLR) improves image quality and res...
BACKGROUND AND OBJECTIVE: Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive, lethal state of prostate cancer, for which early p...
BACKGROUND AND OBJECTIVE: Accurate preoperative prediction of the International Association for the Study of Lung Cancer (IASLC) grades is crucial for...
BACKGROUND AND OBJECTIVE: Three-dimensional (3D) tumor spheroids are widely adopted in preclinical drug screening for their ability to mimic the compl...
BACKGROUND: Lymph node metastasis (LNM) is a critical prognostic indicator in papillary thyroid carcinoma (PTC), significantly influencing surgical de...
OBJECTIVE: To investigate the temporal evolution and predictive value of individual histopathological features of oral epithelial dysplasia (OED) duri...
OBJECTIVES: To assess treatment response in osteosarcoma, two automated convolutional neural networks (CNNs) were developed to quantify tumour volumes...
BACKGROUND: Automated breast ultrasound (ABUS) shows potential for breast cancer diagnosis but faces tumor segmentation challenges due to limited anno...
Surface-Enhanced Raman Spectroscopy (SERS) has become a valuable way to detect small amounts of molecules due to its high sensitivity. Nonetheless, ap...
BACKGROUND AND AIMS: Histological grading of renal cell carcinoma (RCC) is an important part of diagnostic evaluation. Reproducibility of RCC grading ...
Algorithmic decision support is rapidly becoming a staple of personalized medicine, particularly for high-stakes recommendations such as cancer subtyp...
OBJECTIVES: This study aims to achieve accurate differentiation of malignant pleural mesothelioma (MPM) from metastatic pleural disease (MPD) and to p...
The tumor microenvironment (TME) is a complex ecosystem of diverse cell types whose interactions govern tumor growth and clinical outcome. While multi...